Clinical Trial Update: Assess Efficacy of a Nanodiamond Periprocedural Skin Care Regimen for Ablative Resurfacing [Phase 2]

View source ↗

Summary

A Phase 2 trial is planned to assess the efficacy of a nanodiamond periprocedural skin care regimen for ablative resurfacing, with not-yet-recruiting status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Skin Laxity

Drugs mentioned

• Nanodiamond Periprocedural Skin Care Regimen

Snippet

Sponsor: Goldman, Butterwick, Fitzpatrick and Groff | Conditions: Skin Laxity | Phase 2 | Status: NOT_YET_RECRUITING